Single-Session Percutaneous Cholangioscopy for High-Risk Patients with Biliary Stone Disease
摘要
To evaluate the technical and clinical success, as well as the safety, of single-operator, single-session percutaneous cholangioscopy for the management of biliary stone disease.
Materials and MethodsThirty-four non-surgical patients (median age 69 years; 14 female, 20 male) from two tertiary care hospitals underwent 37 percutaneous cholangioscopy–guided stone extraction procedures between March 2023 and August 2025. Patient characteristics, procedural details, technical and clinical success, and complications were retrospectively reviewed.
ResultsTwenty-six patients underwent percutaneous cholecystostomy (PC) and eight underwent percutaneous transhepatic biliary drainage (PTBD) prior to cholangioscopy. Primary technical success was 91.2% (31/34; 95% CI, 76.3–98.1)—88.5% in the PC cohort (23/26) and 100% in the PTBD cohort (8/8). After three repeat procedures, secondary technical success reached 100%. Clinical success, defined as the absence of recurrent cholecystitis or biliary colic, was achieved in 91.2% of patients over a median follow-up of 413 days. The median drain dwell time was 113 days, with a median interval of 14 days from stone extraction to drain removal. Two procedure-related complications occurred—one cystic duct injury and one pleural effusion (CIRSE classification 1a and 3b, respectively)—along with one non-procedure-related complication of prolonged delirium (CIRSE classification 3b).
ConclusionSingle-session percutaneous cholangioscopy–guided biliary stone management demonstrates high technical and clinical success with minimal complications and appears to be a viable treatment option for high-risk patients who are not candidates for surgery or peroral endoscopic interventions.
Graphical Abstract